Barclays maintains Equalweight on Celgene (NASDAQ: CELG) price target of $120.00.Analyst Dr. Geoff Meacham comments "While management tone was optimistic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE